• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌萎缩侧索硬化症的表型变异性。

The phenotypic variability of amyotrophic lateral sclerosis.

机构信息

University of Leuven, Department of Neurosciences, Laboratory for Neurobiology, Vesalius Research Center, Box 912, B-3000 Leuven, Belgium.

出版信息

Nat Rev Neurol. 2014 Nov;10(11):661-70. doi: 10.1038/nrneurol.2014.184. Epub 2014 Oct 14.

DOI:10.1038/nrneurol.2014.184
PMID:25311585
Abstract

Classic textbook neurology teaches that amyotrophic lateral sclerosis (ALS) is a degenerative disease that selectively affects upper and lower motor neurons and is fatal 3-5 years after onset--a description which suggests that the clinical presentation of ALS is very homogenous. However, clinical and postmortem observations, as well as genetic studies, demonstrate that there is considerable variability in the phenotypic expression of ALS. Here, we review the phenotypic variability of ALS and how it is reflected in familial and sporadic ALS, in the degree of upper and lower motor neuron involvement, in motor and extramotor involvement, and in the spectrum of ALS and frontotemporal dementia. Furthermore, we discuss some unusual clinical characteristics regarding presentation, age at onset and disease progression. Finally, we address the importance of this variability for understanding the pathogenesis of ALS and for the development of therapeutic strategies.

摘要

经典的神经科教科书告诉我们,肌萎缩侧索硬化症(ALS)是一种退行性疾病,选择性地影响上下运动神经元,发病后 3-5 年内致命——这一描述表明 ALS 的临床表现非常同质。然而,临床和尸检观察以及遗传研究表明,ALS 的表型表达存在相当大的可变性。在这里,我们回顾了 ALS 的表型变异性,以及它在家族性和散发性 ALS 中、在上运动神经元和下运动神经元受累程度、在运动和非运动受累中的表现,以及在 ALS 和额颞叶痴呆的范围内的表现。此外,我们还讨论了一些关于发病、发病年龄和疾病进展的不寻常的临床特征。最后,我们讨论了这种变异性对理解 ALS 的发病机制和治疗策略的重要性。

相似文献

1
The phenotypic variability of amyotrophic lateral sclerosis.肌萎缩侧索硬化症的表型变异性。
Nat Rev Neurol. 2014 Nov;10(11):661-70. doi: 10.1038/nrneurol.2014.184. Epub 2014 Oct 14.
2
[Genetic coherence between hereditary amyotrophic lateral sclerosis and frontotemporal dementia].[遗传性肌萎缩侧索硬化症与额颞叶痴呆之间的遗传相关性]
Tidsskr Nor Laegeforen. 2014 Feb 11;134(3):302-6. doi: 10.4045/tidsskr.13.0049.
3
Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.9p 染色体上 C9ORF72 突变引起的家族性额颞叶痴呆的临床和病理特征。
Brain. 2012 Mar;135(Pt 3):709-22. doi: 10.1093/brain/awr354. Epub 2012 Feb 17.
4
Genetic analysis of matrin 3 gene in French amyotrophic lateral sclerosis patients and frontotemporal lobar degeneration with amyotrophic lateral sclerosis patients.法国肌萎缩侧索硬化症患者及合并肌萎缩侧索硬化症的额颞叶痴呆患者中核纤层蛋白3基因的遗传分析
Neurobiol Aging. 2014 Dec;35(12):2882.e13-2882.e15. doi: 10.1016/j.neurobiolaging.2014.07.016. Epub 2014 Jul 18.
5
Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1 ) mouse model of amyotrophic lateral sclerosis include sex-dependent phenotypes.肌萎缩侧索硬化症 SOD1 G93A (超氧化物歧化酶 1 )转基因小鼠模型的新型行为特征包括性别依赖性表型。
Genes Brain Behav. 2020 Feb;19(2):e12604. doi: 10.1111/gbb.12604. Epub 2019 Sep 10.
6
Amyotrophic lateral sclerosis and frontotemporal lobar degeneration in association with CADASIL.
Neurologist. 2012 Mar;18(2):92-5. doi: 10.1097/NRL.0b013e318247bb2d.
7
Modeling ALS and FTD with iPSC-derived neurons.利用诱导多能干细胞衍生的神经元对肌萎缩侧索硬化症和额颞叶痴呆进行建模。
Brain Res. 2017 Feb 1;1656:88-97. doi: 10.1016/j.brainres.2015.10.003. Epub 2015 Oct 14.
8
Clinical and neuropathological features of ALS/FTD with TIA1 mutations.伴有 TIA1 突变的肌萎缩侧索硬化症/额颞叶痴呆的临床和神经病理学特征。
Acta Neuropathol Commun. 2017 Dec 7;5(1):96. doi: 10.1186/s40478-017-0493-x.
9
Motor neuron dysfunctions in the frontotemporal lobar degeneration spectrum: a clinical and neurophysiological study.额颞叶变性谱系中的运动神经元功能障碍:一项临床与神经生理学研究
J Neurol Sci. 2015 Apr 15;351(1-2):72-77. doi: 10.1016/j.jns.2015.02.039. Epub 2015 Mar 1.
10
FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis.额颞叶变性伴运动神经元病中的 FUS 突变。
J Alzheimers Dis. 2010;22(3):765-9.

引用本文的文献

1
Respiratory-Onset Amyotrophic Lateral Sclerosis (ALS): A Rare Initial Presentation.呼吸起病型肌萎缩侧索硬化症(ALS):一种罕见的首发表现。
J Gen Intern Med. 2025 Sep 4. doi: 10.1007/s11606-025-09831-w.
2
Understanding the genetics and neurology: an overview of adult neurogenetics.理解遗传学与神经学:成人神经遗传学概述
Asian Biomed (Res Rev News). 2025 Sep 2;19(4):196-208. doi: 10.2478/abm-2025-0022. eCollection 2025 Aug.
3
Network spreading and local biological vulnerability in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中的网络传播与局部生物易损性

本文引用的文献

1
Expanded C9ORF72 hexanucleotide repeat in depressive pseudodementia.抑郁性假性痴呆中 C9ORF72 六核苷酸重复序列的扩展。
JAMA Neurol. 2014 Jun;71(6):775-81. doi: 10.1001/jamaneurol.2013.6368.
2
The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype.C9ORF72 相关疾病谱的扩大;基因型/表型相关性及临床表型的潜在修饰因子。
Acta Neuropathol. 2014 Mar;127(3):333-45. doi: 10.1007/s00401-014-1251-9. Epub 2014 Feb 4.
3
Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration.
Commun Biol. 2025 Aug 4;8(1):1153. doi: 10.1038/s42003-025-08561-3.
4
Disrupted Glucose Metabolism Covariance Network in Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症中葡萄糖代谢协方差网络的破坏
CNS Neurosci Ther. 2025 Jul;31(7):e70537. doi: 10.1111/cns.70537.
5
Thalamic nuclei volumes are related to disease stage in patients with amyotrophic lateral sclerosis.在肌萎缩侧索硬化症患者中,丘脑核体积与疾病阶段相关。
Front Neurosci. 2025 Jul 11;19:1616239. doi: 10.3389/fnins.2025.1616239. eCollection 2025.
6
Trimeric superoxide dismutase 1 antibody as a universal biomarker for ALS.三聚体超氧化物歧化酶1抗体作为肌萎缩侧索硬化症的通用生物标志物。
Res Sq. 2025 Jul 15:rs.3.rs-6941118. doi: 10.21203/rs.3.rs-6941118/v1.
7
LncRNA levels in the central nervous system as novel potential players and biomarkers in amyotrophic lateral sclerosis.长链非编码RNA在中枢神经系统中的水平作为肌萎缩侧索硬化症中的新型潜在参与者和生物标志物
Noncoding RNA Res. 2025 Jun 9;14:145-155. doi: 10.1016/j.ncrna.2025.05.017. eCollection 2025 Oct.
8
Optimizing deep learning models to combat amyotrophic lateral sclerosis (ALS) disease progression.优化深度学习模型以对抗肌萎缩侧索硬化症(ALS)的疾病进展。
Digit Health. 2025 Jun 30;11:20552076251349719. doi: 10.1177/20552076251349719. eCollection 2025 Jan-Dec.
9
A systematic review and functional analysis of genes and variants associated with amyotrophic lateral sclerosis.与肌萎缩侧索硬化相关的基因和变异的系统综述与功能分析。
Front Neurosci. 2025 Jun 16;19:1598336. doi: 10.3389/fnins.2025.1598336. eCollection 2025.
10
Exploring the Role of Diabetes in ALS: A Population-Based Cohort Study.探索糖尿病在肌萎缩侧索硬化症中的作用:一项基于人群的队列研究。
Life (Basel). 2025 Jun 10;15(6):936. doi: 10.3390/life15060936.
神经元基质金属蛋白酶-9 是选择性神经退行性变的决定因素。
Neuron. 2014 Jan 22;81(2):333-48. doi: 10.1016/j.neuron.2013.12.009.
4
Long-term survival in amyotrophic lateral sclerosis: a population-based study.肌萎缩侧索硬化症的长期生存:一项基于人群的研究。
Ann Neurol. 2014 Feb;75(2):287-97. doi: 10.1002/ana.24096. Epub 2014 Feb 24.
5
State of play in amyotrophic lateral sclerosis genetics.肌萎缩侧索硬化症遗传学研究进展。
Nat Neurosci. 2014 Jan;17(1):17-23. doi: 10.1038/nn.3584. Epub 2013 Dec 26.
6
C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies.C9orf72 扩增是亨廷顿病表型模拟最常见的遗传原因。
Neurology. 2014 Jan 28;82(4):292-9. doi: 10.1212/WNL.0000000000000061. Epub 2013 Dec 20.
7
Neuropsychiatric changes precede classic motor symptoms in ALS and do not affect survival.神经精神变化先于经典运动症状出现在 ALS 中,且不影响生存。
Neurology. 2014 Jan 14;82(2):149-55. doi: 10.1212/WNL.0000000000000023. Epub 2013 Dec 11.
8
The epidemiology of ALS: a conspiracy of genes, environment and time.肌萎缩侧索硬化症的流行病学:基因、环境与时间的共谋。
Nat Rev Neurol. 2013 Nov;9(11):617-28. doi: 10.1038/nrneurol.2013.203. Epub 2013 Oct 15.
9
Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival.通过兴奋性和 mTOR 对 ALS 运动神经元进行神经保护,以延缓疾病进展和延长生存期。
Neuron. 2013 Oct 2;80(1):80-96. doi: 10.1016/j.neuron.2013.07.027.
10
Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study.C9ORF72 重复扩增携带者的重复大小与临床和病理特征的相关性(Xpansize-72):一项横断面队列研究。
Lancet Neurol. 2013 Oct;12(10):978-88. doi: 10.1016/S1474-4422(13)70210-2. Epub 2013 Sep 5.